Medication for Opioid Use Disorder and Treatment Retention Among Pregnant Individuals.

ABSTRACT:

Importance

Treatment retention for pregnant individuals with opioid use disorder (OUD) is critical, especially during the high-potency synthetic opioid (HPSO) era. Current data on the relationship between medication for opioid use disorder (MOUD) receipt in specialty substance use treatment facilities and retention are needed for this population.

Objective

To examine the association between MOUD inclusion in treatment and 6-month treatment retention among pregnant individuals with OUD in publicly funded specialty treatment facilities during the HPSO era.

Design, setting, and participants

This cross-sectional study pooled data from January 1, 2015, to December 31, 2021, from the Treatment Episode Data Set-Discharges, a national dataset managed by the Substance Abuse an

SUBMITTER: Ganetsky VS 

PROVIDER: S-EPMC12013350 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature